Manufacturer of APIs are now required to review their manufacturing processes and prove the absence of nitrosamine impurities. This whitepaper outlines the regulations and a case study on how Dr. Reddy’s Sartan API’s (such as Valsartan) already addresses future requirements.

You can review our Sartan portfolio by clicking on the following links:

Valsartan - https://api.drreddys.com/product/valsartan

Losartan - https://api.drreddys.com/product/losartan-potassium

Telmisartan - https://api.drreddys.com/product/telmisartan

Irbesartan - https://api.drreddys.com/product/irbesartan